Ovarian Cysts Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cysts, including details on causes, treatment, symptoms, infertility.

Volume 7 (2010), Issue 10 (October)

1. Prenatal androgen exposure programs metabolic dysfunction in female mice.
   J Endocrinol, 207(2): 213-23. [Abstract] [Full-text]
2. Prenatal androgen exposure programs metabolic dysfunction in female mice.
   J Endocrinol, 207(2): 213-23. [Abstract] [Full-text]
3. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring.
   Am J Physiol Endocrinol Metab, 299(5): E741-51. [Abstract] [Full-text]
4. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring.
   Am J Physiol Endocrinol Metab, 299(5): E741-51. [Abstract] [Full-text]
5. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction.
   Fertil Steril, 94(6): 1949-57. [Abstract] [Full-text]
6. An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome.
   Fertil Steril, 94(6): 2402-5. [Abstract] [Full-text]
7. Association of insulin receptor genetic variants with polycystic ovary syndrome in a population of women from Central Europe.
   Fertil Steril, 94(6): 2389-92. [Abstract] [Full-text]
8. mRNA expression pattern of insulin-like growth factor components of granulosa cells and cumulus cells in women with and without polycystic ovary syndrome according to oocyte maturity.
   Fertil Steril, 94(6): 2417-20. [Abstract] [Full-text]
9. The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome.
   Fertil Steril, 94(6): 2451-4. [Abstract] [Full-text]
10. Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome.
    Fertil Steril, 94(6): 2385-8. [Abstract] [Full-text]
11. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes.
    Fertil Steril, 94(6): 2493-6. [Abstract] [Full-text]
12. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes.
    Fertil Steril, 94(6): 2197-201. [Abstract] [Full-text]
13. Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile women with polycystic ovary syndrome.
    Fertil Steril, 94(6): 2222-7, 2227.e1-3. [Abstract] [Full-text]
14. Effect of different types of ovarian cyst on antral follicle count.
    Fertil Steril, 94(6): 2338-9. [Abstract] [Full-text]
15. Common genetic variation in MTNR1B is associated with serum testosterone, glucose tolerance, and insulin secretion in polycystic ovary syndrome patients.
    Fertil Steril, 94(6): 2486-9, 2489.e1-2. [Abstract] [Full-text]
16. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.
    Fertil Steril, 94(6): 2234-8. [Abstract] [Full-text]
17. Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.
    Fertil Steril, 94(6): 2332-4. [Abstract] [Full-text]
18. Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry.
    Fertil Steril, 94(6): 2228-33. [Abstract] [Full-text]
19. Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction.
    Fertil Steril, 94(6): 2202-7. [Abstract] [Full-text]
20. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.
    Fertil Steril, 94(6): 2214-21. [Abstract] [Full-text]
21. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study.
    Fertil Steril, 94(6): 2208-13. [Abstract] [Full-text]
22. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome.
    Clin Chem, 56(11): 1696-700. [Abstract] [Full-text]
23. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome.
    Clin Chem, 56(11): 1696-700. [Abstract] [Full-text]

© 2004-2011 Ovarian Cysts Research Today. All Rights Reserved.